HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,717,000 | -5.6% | 115,864 | -6.3% | 0.02% | +4.2% |
Q2 2020 | $1,819,000 | -58.2% | 123,652 | -10.1% | 0.02% | -17.2% |
Q3 2018 | $4,354,000 | +8.0% | 137,559 | +32.6% | 0.03% | +11.5% |
Q2 2018 | $4,030,000 | +69.6% | 103,723 | +20.5% | 0.03% | +36.8% |
Q1 2018 | $2,376,000 | +117.4% | 86,077 | +42.5% | 0.02% | +137.5% |
Q4 2017 | $1,093,000 | – | 60,398 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |